Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 116255-48-2
2. Bromuconazole [iso]
3. 1-[[4-bromo-2-(2,4-dichlorophenyl)oxolan-2-yl]methyl]-1,2,4-triazole
4. Phs29zmz81
5. Chebi:81900
6. 1-((4-bromo-2-(2,4-dichlorophenyl)tetrahydro-2-furanyl)methyl)-1h-1,2,4-triazole
7. Bromuconazol
8. Bromuconazole 10 Microg/ml In Cyclohexane
9. Bromuconazole 10 Microg/ml In Acetonitrile
10. Pentitol, 2,5-anhydro-4-bromo-1,3,4-trideoxy-2-c-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)-
11. Hsdb 7419
12. Chipco' Bromuconazole
13. Unii-phs29zmz81
14. Granit
15. Vectra
16. Bromuconazole-2
17. Bromuconazole [mi]
18. Triazole-based Ligand, 16
19. 1-((2rs,4rs,2rs,4sr)-4-bromo-2-(2,4-dichlorophenyl)tetrahydrofurfuryl)-1h-1,2,4-triazole
20. Bromuconazole [hsdb]
21. Dsstox_cid_12531
22. Dsstox_rid_78969
23. Dsstox_gsid_32531
24. Schembl22340
25. Chembl271579
26. Dtxsid9032531
27. Bdbm21165
28. Tox21_302434
29. Akos015903856
30. 1h-1,2,4-triazole, 1-((4-bromo-2-(2,4-dichlorophenyl)tetrahydro-2-furanyl)methyl)-
31. Bromuconazole 100 Microg/ml In Methanol
32. Ncgc00163751-01
33. Ncgc00255388-01
34. Bromuconazole 1000 Microg/ml In Methanol
35. Cas-116255-48-2
36. Ft-0658072
37. C18704
38. Bromuconazol, Pestanal(r), Analytical Standard
39. Q2152394
40. 1-{[4-bromo-2-(2,4-dichlorophenyl)oxolan-2-yl]methyl}-1h-1,2,4-triazole
41. 1-((4-bromo-2-(2,4-dichlorophenyl)tetrahydro-2- Furanyl)methyl)-1h-1,2,4-triazole
42. 1-((2rs,4rs,2rs,4sr)-4-bromo-2-(2,4- Dichlorophenyl)tetrahydrofurfuryl)-1h-1,2,4-triazole
43. 1h-1,2,4-triazole, 1-((4-bromo-2-(2,4- Dichlorophenyl)tetrahydro-2-furanyl)methyl)-
44. 2,5-anhydro-4-bromo-1,3,4-trideoxy-2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)pentitol
| Molecular Weight | 377.1 g/mol |
|---|---|
| Molecular Formula | C13H12BrCl2N3O |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 374.95408 g/mol |
| Monoisotopic Mass | 374.95408 g/mol |
| Topological Polar Surface Area | 39.9 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 352 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Metabolism in animals (rat, cow, hen) is extensive. Nearly 60 different metabolites were detected in the rat, 57 of which had structures assigned. No evidence was found to suggest that the compound and/or its metabolites accumulate in the organs and tissues of those species, even following repeated administration.
Tomlin CDS, ed. Bromuconazole (116255-48-2). In: The e-Pesticide Manual, 13th Edition Version 3.2 (2005-06). Surrey UK, British Crop Protection Council.
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Bromuconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromuconazole, including repackagers and relabelers. The FDA regulates Bromuconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromuconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bromuconazole supplier is an individual or a company that provides Bromuconazole active pharmaceutical ingredient (API) or Bromuconazole finished formulations upon request. The Bromuconazole suppliers may include Bromuconazole API manufacturers, exporters, distributors and traders.
Bromuconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromuconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromuconazole GMP manufacturer or Bromuconazole GMP API supplier for your needs.
A Bromuconazole CoA (Certificate of Analysis) is a formal document that attests to Bromuconazole's compliance with Bromuconazole specifications and serves as a tool for batch-level quality control.
Bromuconazole CoA mostly includes findings from lab analyses of a specific batch. For each Bromuconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromuconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromuconazole EP), Bromuconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromuconazole USP).
LOOKING FOR A SUPPLIER?
